Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

HGH (Somatropin) – Forschungsarchiv – Seite 3 von 7 | SupStack

HGH (Somatropin) – Forschungsarchiv

Studien 1051–1100 von 1262, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

1051RCT2000

Kousta E, Chrisoulidou A, Lawrence NJ, Anyaoku V, Al-Shoumer KA, Johnston DG · Clin Endocrinol (Oxf) (2000)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

HGH (Somatropin) – Forschungsarchiv

The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.

Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: a 1-year, double-blind, randomized, placebo-controlled study.

Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

Artifact in bone mineral measurements during a very low calorie diet: short-term effects of growth hormone.

High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.

Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.

Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.

The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.

Increased mortality associated with growth hormone treatment in critically ill adults.

Strength and its relationship to changes in fat-free mass, total body potassium, total body water and IGF-1 in adults with growth hormone deficiency: effect of treatment with growth hormone.

Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects.

Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.

Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.

Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts.

Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.

Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.

Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.

Long-term treatment with growth hormone has no persisting effect on lipoprotein(a) in patients with Turner's syndrome.

Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.

Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGF-binding protein-3 levels in brain injury.

Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients.

Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study.

Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.

High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.

Synthetic somatostatin analog (octreotide) suppresses daytime growth hormone secretion equivalently in young and older men: preserved pituitary responsiveness to somatostatin's inhibition in aging.

Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury.

Exercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjects.

Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: a randomised, double-blind placebo-controlled study.

Depression of liver protein synthesis during surgery is prevented by growth hormone.

Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial.

Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency.

Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.

Recombinant human growth hormone treatment in children with thalassemia major.

Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.

The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.

Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.

Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.

Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy.

The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.

Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.

Growth hormone attenuates tumor necrosis factor alpha in burned children.

Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.

Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women.

Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.

Growth hormone treatment during suppression of early puberty in adopted girls. Swedish Growth Hormone Advisory Group.

Effect of 6 months of GH treatment on myosin heavy chain composition in GH-deficient patients.

Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.